Kodiak Sciences

Kodiak Sciences

Kodiak Sciences

Through innovative science and business, Kodiak Sciences is designing and developing novel therapies for the treatment of retinal disease.
Type
B2b
Founded
2009
Raised
$67M
Follow us
Alexa global traffic share
Latest funding
$33,000,000
Venture capital - 2018
Perceptive Advisors ArrowMark Partners
$34,000,000
Venture capital (Series B) - 2016
Team Size
10+
Employees
PE HUB

Kodiak debuts IPO

PE HUB

Kodiak Sciences sets IPO pricing terms

Xconomy

Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies

$33,000,000 Venture capital
FinSMEs

Kodiak Sciences Closes $33M Mezzanine Private Financing

Funding
$34,000,000 Venture capital (Series B)
vcaonline

Venture Capital Access Online | Venture Capital News